KalVista Pharmaceuticals, Inc (KALV) insider trading
Every open-market stock purchase and sale by KalVista Pharmaceuticals, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $7.1M over the last 12 months (38 sales). No open-market buys.
- Last insider buy: Venrock Healthcare Capital Partners III L.P. (Insider), $236K, 18 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $7.1M (38 sales). Last close $27.00 on Jun 10, 2026.
Recent KALV insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 11, 2026 | Paul K. Audhya (C-suite exec) | Sold (not open market) | $2.5M |
| Jun 11, 2026 | Benjamin L Palleiko (CEO) | Sold (not open market) | $1.9M |
| Jun 11, 2026 | Christopher Yea (C-suite exec) | Sold (not open market) | $1.6M |
| Jun 11, 2026 | Benjamin L Palleiko (CEO) | Sold (not open market) | $1.4M |
| Jun 11, 2026 | Brian Piekos (CFO) | Sold (not open market) | $1.2M |
| Jun 11, 2026 | Bilal Arif (C-suite exec) | Sold (not open market) | $1.1M |
| Jun 11, 2026 | Nicole Sweeny (C-suite exec) | Sold (not open market) | $951K |
| Jun 11, 2026 | Benjamin L Palleiko (CEO) | Sold (not open market) | $909K |
| Jun 11, 2026 | Benjamin L Palleiko (CEO) | Sold (not open market) | $867K |
| Jun 11, 2026 | Christopher Yea (C-suite exec) | Sold (not open market) | $846K |
| Jun 11, 2026 | Benjamin L Palleiko (CEO) | Sold (not open market) | $846K |
| Jun 11, 2026 | Benjamin L Palleiko (CEO) | Sold (not open market) | $818K |
| Jun 11, 2026 | Christopher Yea (C-suite exec) | Sold (not open market) | $816K |
| Jun 11, 2026 | Christopher Yea (C-suite exec) | Sold (not open market) | $751K |
| Jun 11, 2026 | Christopher Yea (C-suite exec) | Sold (not open market) | $676K |
| Jun 11, 2026 | Benjamin L Palleiko (CEO) | Sold (not open market) | $589K |
| Jun 11, 2026 | Bethany Sensenig (Insider) | Sold (not open market) | $542K |
| Jun 11, 2026 | Nancy Stuart (Insider) | Sold (not open market) | $480K |
| Jun 11, 2026 | Christopher Yea (C-suite exec) | Sold (not open market) | $439K |
| Jun 11, 2026 | Benjamin L Palleiko (CEO) | Sold (not open market) | $416K |
| Jun 11, 2026 | Benjamin L Palleiko (CEO) | Sold (not open market) | $397K |
| Jun 11, 2026 | Edward W Unkart (Insider) | Sold (not open market) | $362K |
| Jun 11, 2026 | Nancy Stuart (Insider) | Sold (not open market) | $362K |
| Jun 11, 2026 | Patrick Treanor (Insider) | Sold (not open market) | $362K |
| Jun 11, 2026 | William Fairey (Insider) | Sold (not open market) | $362K |
Who's trading KALV
- Christopher Yea, C-suite exec: sold $1.2M (8 sales), last Jun 11, 2026
- Paul K. Audhya, C-suite exec: sold $430K (8 sales), last Jun 11, 2026
- Patrick Treanor, Insider: other filings, last Jun 11, 2026
- Edward W Unkart, Insider: other filings, last Jun 11, 2026
- Bilal Arif, C-suite exec: other filings, last Jun 11, 2026
- William Fairey, Insider: other filings, last Jun 11, 2026
- Benjamin L Palleiko, CEO: sold $1.3M (12 sales), last Jun 11, 2026
- Brian JG Pereira, Insider: other filings, last Jun 11, 2026
- Brian Piekos, CFO: sold $165K (4 sales), last Jun 11, 2026
- Laurence Reid, Insider: other filings, last Jun 11, 2026
- Bethany Sensenig, Insider: other filings, last Jun 11, 2026
- Nancy Stuart, Insider: other filings, last Jun 11, 2026
- Nicole Sweeny, C-suite exec: sold $241K (5 sales), last Jun 11, 2026
- Venrock Healthcare Capital Partners III L.P., Insider: sold $3.7M (5 sales), last Mar 26, 2026
Get free alerts when an insider at KalVista Pharmaceuticals, Inc files a new trade →